Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Request a Protocol
Ask a
question
Favorite
All patients aged 10 to 92 years who were treated with FMT for refractory, recurrent, or severe CDI in all five centers were included. Donor selection, FMT procedure and patient follow-up were the same as those described in our earlier report[20], and they were carried out according to practice guidelines[24]. Capsule FMT was administrated following practice guidelines as reported elsewhere[6,7].
Copyright and License information: ©2018 The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
